Earlier this year, UCL licensed a gene therapy programme for haemophilia A to BioMarin Pharmaceuticals. As a result, the treatment will get access to the marketplace, and 皇家华人ill receive funds from any profits, that it will then plough back into research. Such collaboration offers a win-win scenario for all involved.
Close
